KF
LPCN icon

Krilogy Financial’s Lipocine LPCN Stock Holding History

Krilogy Financial’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24
Closed -$2K – 810
2017
Q3 		$2K Hold
24
– – ﹤0.01% 739
2017
Q2 		$2K Hold
24
– – ﹤0.01% 666
2017
Q1 		$1K Hold
24
– – ﹤0.01% 682
2016
Q4 		$1K Hold
24
– – ﹤0.01% 682
2016
Q3 		$2K Hold
24
– – ﹤0.01% 665
2016
Q2 		$1K Buy
+24
New +$3.72K ﹤0.01% 718

Other funds holding LPCN

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

Krilogy Financial's LPCN Position: Q4 2017 in Review

Krilogy Financial sold out of Lipocine (LPCN) in Q4 2017, closing a stake of 24 shares — an estimated $2K sold.

Krilogy Financial first reported a position in LPCN in Q2 2016 and held it in 6 quarters. The position peaked at $2K in Q3 2017. 39 funds tracked by Wall St. Rank hold LPCN as of Q4 2017.

  • Krilogy Financial reported no remaining Lipocine position as of Q4 2017 after selling out during the quarter.
  • Krilogy Financial sold 24 Lipocine shares in Q4 2017, an estimated $2K.
  • Krilogy Financial first reported a position in Lipocine in Q2 2016 and held it in 6 quarters.
  • Krilogy Financial's Lipocine position peaked at $2K in Q3 2017.
  • 39 funds tracked by Wall St. Rank held Lipocine as of Q4 2017.

Based on Krilogy Financial's 13F filing for Q4 2017, filed 14 Feb 2018.